These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Boyle JJ Curr Vasc Pharmacol; 2005 Jan; 3(1):63-8. PubMed ID: 15638783 [TBL] [Abstract][Full Text] [Related]
17. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence. Björkbacka H; Fredrikson GN; Nilsson J Atherosclerosis; 2013 Mar; 227(1):9-17. PubMed ID: 23177975 [TBL] [Abstract][Full Text] [Related]
18. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques. Rai V; Agrawal DK Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820 [TBL] [Abstract][Full Text] [Related]
19. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Tedgui A; Mallat Z Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268 [TBL] [Abstract][Full Text] [Related]
20. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease]. Galle J Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]